A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Evidence has indicated an association between depression and low dietary intake of omega-3 polyunsaturated fatty acids (PUFAs). However, clinical trials examining the therapeutic benefit of omega-3 PUFAs in depression showed inconsistent results. The goal of this study is to systematically evaluate the antidepressant efficacy of omega-3 PUFAs by using meta-analytic method. DATA SOURCES: MEDLINE, Embase, and PsycINFO databases were searched from 1966 through August 2006 using the key words (depression OR depressive disorder OR mood disorder) AND (omega-3 OR EPA OR DHA OR poly-unsaturated fatty acid OR fish oil). The search was limited to literature in English and clinical trials. STUDY SELECTION: Ten double-blind, placebo-controlled studies in patients with mood disorders receiving omega-3 PUFAs with the treatment period lasting 4 weeks or longer were included. DATA EXTRACTION: Effect size (ES) of each individual study was derived by computing the standardized mean difference. A random-effects model was used to pool the ESs of all included studies. DATA SYNTHESIS: When pooling the results of 10 included studies (N = 329), we found a significant antidepressant effect of omega-3 PUFAs (ES = 0.61, p = .003). Likewise, omega-3 PUFAs significantly improved depression in patients with clearly defined depression (ES = 0.69, p = .002) or with bipolar disorder (ES = 0.69, p = .0009). The dosage of eicosapentaenoic acid (EPA) did not change the antidepressant efficacy significantly. However, significant heterogeneity among these studies and publication bias were noted. CONCLUSIONS: Although our meta-analysis showed significant antidepressant efficacy of omega-3 PUFAs, it is still premature to validate this finding due to publication bias and heterogeneity. More large-scale, well-controlled trials are needed to find out the favorable target subjects, therapeutic dose of EPA, and the composition of omega-3 PUFAs in treating depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a meta-analysis reported direct antidepressant effects when combining all sources of omega-3 fatty acids”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Lin and Su, 2007
In the citing paper
“Also, lately some studies suggested that omega-3-fatty acids, initially given as adjuvant in psychotropic treatment of depressive disorder [297–299], can be extremely useful in MDD therapy [300].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [299]
Citations
Cites
Still being checked.
Cited by
(2009) · Cited by 2,013
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3820 · Cited by 1,605
Omega-3 polyunsaturated fatty acids and their health benefits
Shahidi, F., & Ambigaipalan, P. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111317-095850 · Cited by 1,390
Davydov, D. M., Stewart, R., Ritchie, K., & Chaudieu, I. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.003 · Cited by 1,189
“Another proposed example are omega-3 fatty acid fortification programs, which may have both harm-reduction and health promotion effects for mental health (Freeman et al., 2006; Hibbeln, Ferguson & Blasbalg, 2006; Harris, 2007; Lin & Su, 2007; McNamara et al., 2009).”
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
“003) (Lin and Su, 2007).”
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Walsh, R. (2011) · American Psychologist · doi:10.1037/a0021769 · Cited by 692
Dietary pattern and depressive symptoms in middle age
Akbaraly, T. N., Brunner, E. J., Ferrie, J. E., Marmot, M. G., Kivimaki, M., & Singh-Manoux, A. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.058925 · Cited by 602
“Research on the association between diet and depression has focused primarily on nutrients such as fatty acids (1-4) and nutrients involved in the homocysteine pathway, e.”
The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
Iwata, M., Ota, K. T., & Duman, R. S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.12.008 · Cited by 580
“Similarly, a meta-analysis of eicosapentaenoic acid (EPA), an omega-3 fatty acid with anti-inflammatory properties, shows that it has antidepressant actions (Block et al., 2012; Lin and Su, 2007).”
BackgroundA meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Self-citationMoylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
Kennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
“There is an unrealized opportunity to increase our knowledge on this topic by incorporating CVD-related measures in studies of youth with MDD and BD. Traditional CVD risk factors and high-sensitivity CRP, as well as ascertainment of CVD-related family medical history, can be readily and inexpensively measured and shou…”
ResultInfluentialGrosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096905 · Cited by 449
Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression
Sublette, M. E., Ellis, S. P., Geant, A. L., & Mann, J. J. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06634 · Cited by 417
Diet, Stress and Mental Health
Bremner, J., Moazzami, K., Wittbrodt, M., Nye, J., Lima, B., Gillespie, C., Rapaport, M., Pearce, B., Shah, A., & Vaccarino, V. (2020) · Nutrients · doi:10.3390/nu12082428 · Cited by 377
Martins, J. G. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719785 · Cited by 358
Appleton, K. M., Rogers, P. J., & Ness, A. R. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28313 · Cited by 353
Omega-3 fatty acids and depression: scientific evidence and biological mechanisms
Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/313570 · Cited by 351
“Previous meta-analytic studies reported a general positive effect of omega-3 PUFA intake on ameliorating symptoms of depression [79, 80].”
ResultSingh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Omega-3 fatty acids: a comprehensive review of their role in health and disease
Yashodhara, B. M., Umakanth, S., Pappachan, J. M., Bhat, S. K., Kamath, R., & Choo, B. H. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.073338 · Cited by 335
Zunszain, P. A., Hepgul, N., & Pariante, C. M. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_211 · Cited by 303
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Metabolic disturbances connecting obesity and depression
Hryhorczuk, C., Sharma, S., & Fulton, S. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00177 · Cited by 322
Brain membrane lipids in major depression and anxiety disorders
Müller, C. P., Reichel, M., Mühle, C., Rhein, C., Gulbins, E., & Kornhuber, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.014 · Cited by 308
Su, K.-P., Huang, S.-Y., Chiu, T.-H., Huang, K.-C., Huang, C.-L., Chang, H.-C., & Pariante, C. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0418 · Cited by 308
Self-citationOmega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
Bloch, M. H., & Hannestad, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293
Health benefits of marine foods and ingredients
Larsen, R., Eilertsen, K.-E., & Elvevoll, E. O. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.05.017 · Cited by 294
Rapaport, M. H., Nierenberg, A. A., Schettler, P. J., Kinkead, B., Cardoos, A., Walker, R., & Mischoulon, D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.22 · Cited by 265
Bays, H. E., Tighe, A. P., Sadovsky, R., & Davidson, M. H. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.391 · Cited by 265
Depression and Heart Failure: The Lonely Comorbidity
Sbolli, M., Fiuzat, M., Cani, D., & O’Connor, C. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1865 · Cited by 232
Chang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.160 · Cited by 248
Self-citationStress exposure, food intake and emotional state.
Ulrich‐Lai, Y. M., Fulton, S., Wilson, M., Petrovich, G. D., & Rinaman, L. (2015) · PubMed · doi:10.3109/10253890.2015.1062981 · Cited by 208
Su, K.-P., Lai, H.-C., Yang, H.-T., Su, W.-P., Peng, C.-Y., Chang, J. P.-C., Chang, H.-C., & Pariante, C. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.008 · Cited by 205
Self-citationda Silva, T. M., Munhoz, R. P., Alvarez, C., Naliwaiko, K., Kiss, Á., Andreatini, R., & Ferraz, A. C. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.008 · Cited by 205
Guu, T.-W., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R. K., Hamazaki, K., Freeman, M. P., Maes, M., Matsuoka, Y. J., Belmaker, R. H., et al. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000502652 · Cited by 191
Self-citationRyan, A. S., Astwood, J. D., Gautier, S., Kuratko, C. N., Nelson, E. B., & Salem, N. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2010.02.007 · Cited by 192
Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data
Bozzatello, P., Brignolo, E., De Grandi, E., & Bellino, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5080067 · Cited by 179
Omega-3 fatty acids and mental health
Lange, K. W. (2020) · Global Health Journal · doi:10.1016/j.glohj.2020.01.004 · Cited by 171
de Melo, L. G. P., Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Galecki, P., Carvalho, A. F., & Maes, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 189
“Eicosapentaenoic acid (EPA), one of the ω3 PUFAs, has a significant antidepressant activity (Lin and Su, 2007), probably due to suppression of pro-inflammatory products and Th-1-like cytokines and enhancing neurogenesis (Song and Wang, 2011).”
Lu, D.-Y., Tsao, Y.-Y., Leung, Y.-M., & Su, K.-P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.98 · Cited by 179
Self-citationFish, Mercury, Selenium and Cardiovascular Risk: Current Evidence and Unanswered Questions
Mozaffarian, D. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6061894 · Cited by 182
Mediterranean diet and depressive symptoms among older adults over time
Skarupski, K. A., Tangney, C. C., Li, H., Evans, D. A., & Morris, M. C. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0437-x · Cited by 173
Omega-3 fatty acids for depression in adults
Appleton, K. M., Sallis, H. M., Perry, R., Ness, A. R., & Churchill, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004692.pub4 · Cited by 180
Lipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Diet and the risk of unipolar depression in adults: systematic review of cohort studies
Sanhueza, C., Ryan, L., & Foxcroft, D. R. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2012.01283.x · Cited by 167
Essential fatty acids and human brain.
Chang, C., Ke, D.-S., & Chen, J. (2009) · PubMed · Cited by 216
Su, K.-P., Huang, S.-Y., Peng, C.-Y., Lai, H.-C., Huang, C.-L., Chen, Y.-C., Aitchison, K. J., & Pariante, C. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.005 · Cited by 165
Self-citationSu, K.-P. (2009) · Neurosignals · doi:10.1159/000198167 · Cited by 168
Self-citationMaes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
Lucas, M., Mirzaei, F., O’Reilly, E. J., Pan, A., Willett, W. C., Kawachi, I., Koenen, K., & Ascherio, A. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.011817 · Cited by 166
Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder
Gertsik, L., Poland, R. E., Bresee, C., & Rapaport, M. H. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f3b5f · Cited by 162
PromisingInterventions, O’Connell, M. E., Boat, T. F., & Warner, K. E. (2009) · Cited by 188
Shearer, G. C., Harris, W. S., Pedersen, T. L., & Newman, J. W. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m900193-jlr200 · Cited by 152
Omega 3 polyunsaturated fatty acids and the treatment of depression
Deacon, G., Kettle, C., Hayes, D., Dennis, C., & Tucci, J. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.876959 · Cited by 142
Jaremka, L. M., Lindgren, M. E., & Kiecolt-Glaser, J. K. (2013) · Depression and Anxiety · doi:10.1002/da.22078 · Cited by 137
Omega 3 Fatty Acids and COVID-19: A Comprehensive Review
Hathaway, D., Pandav, K. B., Patel, M., Riva-Moscoso, A., Singh, B. M., Patel, A., Min, Z. C., Makkar, S. S., Sana, M. K., Sanchez-Dopazo, R., et al. (2020) · Infection and Chemotherapy · doi:10.3947/ic.2020.52.4.478 · Cited by 163
Lin, P.-Y., Mischoulon, D., Freeman, M. P., Matsuoka, Y., Hibbeln, J., Belmaker, R. H., & Su, K.-P. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.111 · Cited by 145
Self-citationMartins, J. G., Bentsen, H., & Puri, B. K. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.25 · Cited by 150
Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders
Su, K.-P., Matsuoka, Y., & Pae, C.-U. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.2.129 · Cited by 134
Self-citationCarney, R. M., Freedland, K. E., Rubin, E. H., Rich, M. W., Steinmeyer, B. C., & Harris, W. S. (2009) · JAMA · doi:10.1001/jama.2009.1487 · Cited by 141
Van Dael, P. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.2.137 · Cited by 138
“Several lines of evidence have suggested the efficacy of n-3 LCPUFA as a MDD risk reduction or dietary management strategy in epidemiological and case-controlled studies [98,99], randomized-controlled trials [100-110], and meta-analyses [111-120].”
BackgroundFreeman, M. P., Fava, M., Lake, J., Trivedi, M. H., Wisner, K. L., & Mischoulon, D. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10cs05959blu · Cited by 134
Complementary therapies for clinical depression: an overview of systematic reviews
Haller, H., Anheyer, D., Cramer, H., & Dobos, G. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028527 · Cited by 151
Barberger-Gateau, P., Samieri, C., Feart, C., & Plourde, M. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391926 · Cited by 126
McNamara, R. K., Jandacek, R., Rider, T., Tso, P., Dwivedi, Y., & Pandey, G. N. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.015 · Cited by 129
Omega–6/Omega–3 Essential Fatty Acids: Biological Effects
Simopoulos, A. P. (2008) · World review of nutrition and dietetics · doi:10.1159/000192755 · Cited by 175
Bioequivalence of encapsulated and microencapsulated fish-oil supplementation
Barrow, C. J., Nolan, C., & Holub, B. J. (2008) · Journal of Functional Foods · doi:10.1016/j.jff.2008.09.006 · Cited by 129
Schefft, C., Kilarski, L. L., Bschor, T., & Köhler, S. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.07.004 · Cited by 135
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9210-2 · Cited by 144
Role of fish oil in human health and possible mechanism to reduce the inflammation
Ellulu, M. S., Khaza’ai, H., Abed, Y. A., Rahmat, A. B., Ismail, P., & Ranneh, Y. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0228-1 · Cited by 146
Jayedi, A., & Shab-Bidar, S. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa029 · Cited by 124
Low Omega-3 Index in Pregnancy Is a Possible Biological Risk Factor for Postpartum Depression
Markhus, M. W., Skotheim, S., Graff, I. E., Frøyland, L., Braarud, H. C., Stormark, K. M., & Malde, M. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067617 · Cited by 116
Omega-3 long-chain polyunsaturated fatty acids: Metabolism and health implications
Khan, I. R., Hussain, M., Jiang, B., Zheng, L., Pan, Y., Hu, J., Khan, A., Ashraf, A., & Zou, X. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101255 · Cited by 138
Stapelberg, N. J. C., Neumann, D. L., Shum, D. H. K., McConnell, H., & Hamilton-Craig, I. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.570427 · Cited by 116
The Role of Essential Fatty Acids in Human Health
Glick, N. R., & Fischer, M. H. (2013) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587213488788 · Cited by 133
Ravindran, A. V., & da Silva, T. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.042 · Cited by 121
The role of lipid biomarkers in major depression
Parekh, A., Smeeth, D., Milner, Y., & Thuret, S. (2017) · Healthcare · doi:10.3390/healthcare5010005 · Cited by 120
Suicide Deaths of Active-Duty US Military and Omega-3 Fatty-Acid Status: A Case-Control Comparison
Lewis, M. D., Hibbeln, J. R., Johnson, J. E., Lin, Y. H., Hyun, D. Y., & Loewke, J. D. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m06879 · Cited by 117
Rondanelli, M., Giacosa, A., Opizzi, A., Pelucchi, C., La Vecchia, C., Montorfano, G., Negroni, M., Berra, B., Politi, P., & Rizzo, A. M. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719817 · Cited by 118
Féart, C., Peuchant, E., Letenneur, L., Samieri, C., Montagnier, D., Fourrier‐Réglat, A., & Barberger‐Gateau, P. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1156 · Cited by 122
Background Paper on Fat and Fatty Acid Requirements during Pregnancy and Lactation
Brenna, J. T., & Lapillonne, A. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000228998 · Cited by 116
Appleton, K. M., Rogers, P. J., & Ness, A. R. (2008) · Nutrition Research Reviews · doi:10.1017/s0954422408998620 · Cited by 117
Jazayeri, S., Keshavarz, S. A., Tehrani-Doost, M., Djalali, M., Hosseini, M., Amini, H., Chamari, M., & Djazayery, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.04.013 · Cited by 116
“Treatment studies have suggested that omega-3 fatty acids (ω-3 FAs) as monotherapy or adjunctive treatment have therapeutic effects in depression (Freeman et al., 2006; Lin and Su, 2007).”
Docosahexaenoic acid, 22:6n‐3: Its roles in the structure and function of the brain
Mallick, R., Basak, S., & Duttaroy, A. K. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.10.004 · Cited by 124
Omega-3 Fatty Acids in Psychiatry
Mischoulon, D., & Freeman, M. P. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.12.002 · Cited by 111
Are dietary recommendations for the use of fish oils sustainable?
Jenkins, D. J. A., Sievenpiper, J. L., Pauly, D., Sumaila, U. R., Kendall, C. W. C., & Mowat, F. M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081274 · Cited by 115
Lucas, M., Asselin, G., Mérette, C., Poulin, M.-J., & Dodin, S. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26749 · Cited by 119
Therapeutic use of omega-3 fatty acids in bipolar disorder
Balanzá-Martínez, V., Fries, G. R., Colpo, G. D., Silveira, P. P., Portella, A. K., Tabarés-Seisdedos, R., & Kapczinski, F. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.42 · Cited by 101
The Nutritional Significance of Lipid Rafts
Yaqoob, P. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141205 · Cited by 102
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
McNamara, R. K., & Lotrich, F. E. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.98 · Cited by 108
Randomized, placebo‐controlled trial of flax oil in pediatric bipolar disorder
Gracious, B., Chirieac, M., Costescu, S., Finucane, T. L., Youngstrom, E. A., & Hibbeln, J. R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00799.x · Cited by 110
Ravindran, A. V., Lam, R. W., Filteau, M. J., Lespérance, F., Kennedy, S. H., Parikh, S. V., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.040 · Cited by 108
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“Also, lately some studies suggested that omega-3-fatty acids, initially given as adjuvant in psychotropic treatment of depressive disorder [297–299], can be extremely useful in”
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 115
Doornbos, B., van Goor, S. A., Dijck-Brouwer, D. A. J., Schaafsma, A., Korf, J., & Muskiet, F. A. J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.003 · Cited by 100
Liu, H., Luiten, P. G. M., Eisel, U. L. M., DeJongste, M. J. L., & Schoemaker, R. G. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.004 · Cited by 101
Metadata
- Authors
- Lin, P.-Y., & Su, K.-P.
- Affiliations
- Chang Gung University (TW)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-07-15
- Volume
- 68
- Issue
- 07
- Pages
- 1056-1061
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1986373853
- Cited by
- 481
- References
- 0
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 9 · 2021: 16 · 2020: 23 · 2019: 23 · 2018: 18 · 2017: 22 · 2016: 25 · 2015: 33 · 2014: 30 · 2013: 39 · 2012: 32
- FWCI
- 41.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- omega-3 polyunsaturated fatty acids, antidepressant efficacy, depression, bipolar disorder, eicosapentaenoic acid, docosahexaenoic acid, fish oil, mood disorders, dietary fatty acids
- MeSH terms
- Adult, Bipolar Disorder, Depressive Disorder, Double-Blind Method, Humans, Middle Aged, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.